The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
Open accessAbstract
BACKGROUND: We aimed to investigate the prognostic value of tumour-infiltrating lymphocytes' (TILs) expression in pretreatment specimens from patients with head and neck squamous cell carcinoma (HNSCC) treated with definitive chemoradiotherapy (CRT). METHODS: The prevalence of CD3+, CD8+, CD4+ and FOXP3+ TILs was assessed using immunohistochemistry in tumour tissue obtained from 101 patients before CRT and was correlated with clinicopathological characteristics as well as local failure-free- (LFFS), distant metastases free- (DMFS), progression-free (PFS) and overall survival (OS). Survival curves were measured using the Kaplan-Meier method, and differences in survival between the groups were estimated using the log-rank test. Prognostic effects of TIL subset density were determined using the Cox regression analysis. RESULTS: With a mean follow-up of 25 months (range, 2.3-63 months), OS at 2 years was 57.4% for the entire cohort. Patients with high immunohistochemical CD3 and CD8 expression had significantly increased OS (P=0.024 and P=0.028), PFS (P=0.044 and P=0.047) and DMFS (P=0.021 and P=0.026) but not LFFS (P=0.90 and P=0.104) in multivariate analysis that included predictive clinicopathologic factors, such as age, sex, T-stage, N-stage, tumour grading and localisation. Neither CD4 nor FOXP3 expression showed significance for the clinical outcome. The lower N-stage was associated with improved OS in the multivariate analysis (P=0.049). CONCLUSION: The positive correlation between a high number of infiltrating CD3+ and CD8+ cells and clinical outcome indicates that TILs may have a beneficial role in HNSCC patients and may serve as a biomarker to identify patients likely to benefit from definitive CRT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912217 · Cited by 6,566
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4596 · Cited by 3,638
Fakhry, C., Westra, W. H., Li, S., Cmelak, A., Ridge, J. A., Pinto, H., Forastiere, A., & Gillison, M. L. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn011 · Cited by 2,779
Argiris, A., Karamouzis, M. V., Raben, D., & Ferris, R. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60728-x · Cited by 2,224
Denkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,762
Dewan, M. Z., Galloway, A. E., Kawashima, N., Dewyngaert, J. K., Babb, J. S., Formenti, S. C., & Demaria, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0265 · Cited by 1,678
Gooden, M. J. M., de Bock, G. H., Leffers, N., Daemen, T., & Nijman, H. W. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.189 · Cited by 1,277
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
Formenti, S. C., & Demaria, S. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs629 · Cited by 1,053
Zeng, J., See, A. P., Phallen, J., Jackson, C. M., Belcaid, Z., Ruzevick, J., Durham, N., Meyer, C., Harris, T. J., Albesiano, E., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.12.025 · Cited by 889
Burnette, B. C., Liang, H., Lee, Y., Chlewicki, L., Khodarev, N. N., Weichselbaum, R. R., Fu, Y.-X., & Auh, S. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2820 · Cited by 878
Rischin, D., Young, R. J., Fisher, R., Fox, S. B., Le, Q.-T., Peters, L. J., Solomon, B., Choi, J., O'Sullivan, B., Kenny, L. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.2904 · Cited by 737
Lassen, P., Eriksen, J. G., Hamilton-Dutoit, S., Tramm, T., Alsner, J., & Overgaard, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.2853 · Cited by 612
Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers
Badoual, C., Hans, S., Rodriguez, J., Peyrard, S., Klein, C., Agueznay, N. E. H., Mosseri, V., Laccourreye, O., Bruneval, P., Fridman, W. H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1886 · Cited by 598
Pyeon, D., Newton, M. A., Lambert, P. F., den Boon, J. A., Sengupta, S., Marsit, C. J., Woodworth, C. D., Connor, J. P., Haugen, T. H., Smith, E. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3619 · Cited by 460
Cancer immunotherapy – revisited
Lesterhuis, W. J., Haanen, J. B. A. G., & Punt, C. J. A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3500 · Cited by 427
Ginos, M. A., Page, G. P., Michalowicz, B. S., Patel, K. J., Volker, S. E., Pambuccian, S. E., Ondrey, F. G., Adams, G. L., & Gaffney, P. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2144 · Cited by 407
Kawai, O., Ishii, G., Kubota, K., Murata, Y., Naito, Y., Mizuno, T., Aokage, K., Saijo, N., Nishiwaki, Y., Gemma, A., et al. (2008) · Cancer · doi:10.1002/cncr.23712 · Cited by 384
Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer
Kimple, R. J., Smith, M. A., Blitzer, G. C., Torres, A. D., Martin, J. A., Yang, R. Z., Peet, C. R., Lorenz, L. D., Nickel, K. P., Klingelhutz, A. J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0587 · Cited by 366
What are regulatory T cells (Treg) regulating in cancer and why?
Whiteside, T. L. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.03.004 · Cited by 291
(1979) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/63.5.1229 · Cited by 263
Galectin-1: A Link Between Tumor Hypoxia and Tumor Immune Privilege
Le, Q.-T., Shi, G., Cao, H., Nelson, D. W., Wang, Y., Chen, E. Y., Zhao, S., Kong, C., Richardson, D., O'Byrne, K. J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0206 · Cited by 258
PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis
Zinselmeyer, B. H., Heydari, S., Sacristán, C., Nayak, D., Cammer, M., Herz, J., Cheng, X., Davis, S. J., Dustin, M. L., & McGavern, D. B. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121416 · Cited by 258
Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients
Deschoolmeester, V., Baay, M., Van Marck, E., Weyler, J., Vermeulen, P., Lardon, F., & Vermorken, J. B. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-19 · Cited by 235
Dahlin, A. M., Henriksson, M. L., Van Guelpen, B., Stenling, R., Öberg, Å., Rutegård, J., & Palmqvist, R. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.234 · Cited by 228
Lieberman, J., Shankar, P., Manjunath, N., & Andersson, J. (2001) · Blood · doi:10.1182/blood.v98.6.1667 · Cited by 226
Kong, C. S., Narasimhan, B., Cao, H., Kwok, S., Erickson, J. P., Koong, A., Pourmand, N., & Le, Q.-T. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.015 · Cited by 212
Reichert, T. E., Strauss, L., Wagner, E. M., Gooding, W. E., & Whiteside, T. L. (2002) · PubMed · Cited by 211
Näsman, A., Romanitan, M., Nordfors, C., Grün, N., Johansson, H., Hammarstedt, L., Marklund, L., Munck-Wikland, E., Dalianis, T., & Ramqvist, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038711 · Cited by 199
Nordfors, C., Grün, N., Tertipis, N., Ährlund-Richter, A., Haeggblom, L., Sivars, L., Du, J., Nyberg, T., Marklund, L., Munck-Wikland, E., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.03.019 · Cited by 197
Ogino, T., Shigyo, H., Ishii, H., Katayama, A., Miyokawa, N., Harabuchi, Y., & Ferrone, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0488 · Cited by 189
Pretscher, D., Distel, L. V., Grabenbauer, G. G., Wittlinger, M., Buettner, M., & Niedobitek, G. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-292 · Cited by 186
Infiltrating lymphocytes and human papillomavirus‐16–associated oropharyngeal cancer
Wansom, D., Light, E., Thomas, D., Worden, F. P., Prince, M. E., Urba, S. G., Chepeha, D. B., Kumar, B., Cordell, K. G., Eisbruch, A., et al. (2011) · The Laryngoscope · doi:10.1002/lary.22133 · Cited by 153
Harnessing the immune system to treat cancer
Bhardwaj, N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32136 · Cited by 152
Dovedi, S. J., Melis, M. H. M., Wilkinson, R. W., Adlard, A. L., Stratford, I. J., Honeychurch, J., & Illidge, T. (2012) · Blood · doi:10.1182/blood-2012-05-432393 · Cited by 150
Grabenbauer, G. G., Lahmer, G., Distel, L. V., & Niedobitek, G. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2434 · Cited by 142
Distel, L. V., Fickenscher, R., Dietel, K., Hung, A., Iro, H., Zenk, J., Nkenke, E., Büttner, M., Niedobitek, G., & Grabenbauer, G. G. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2009.05.640 · Cited by 110
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia
Bontkes, H. J., de Gruijl, T. D., van den Muysenberg, A. J. C., Verheijen, R. H. M., Stukart, M. J., Meijer, C. J. L. M., Scheper, R. J., Stacey, S., Duggan-Keen, M. F., Stern, P. L., et al. (2000) · International Journal of Cancer · Cited by 89
Nedergaard, B. S., Ladekarl, M. B., Thomsen, H. F., Nyengaard, J. R., & Nielsen, K. N. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604001 · Cited by 88
Predicting Recurrence After Radiotherapy in Head and Neck Cancer
Begg, A. C. (2012) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2011.12.002 · Cited by 70
Ducray, F., de Reyniès, A., Chinot, O. L., Idbaïh, A., Figarella‐Branger, D., Colin, C., Karayan, L., Chneiweiss, H., Wager, M., Vallette, F. M., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-234 · Cited by 51
Cited by
Hendry, S., Salgado, R., Gevaert, T., Russell, P. A., John, T., Thapa, B., Christie, M., van de Vijver, K., Estrada, M. V., Gonzalez-Ericsson, P. I., et al. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000161 · Cited by 799
Solomon, B., Young, R. J., & Rischin, D. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.01.008 · Cited by 467
HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer
Barnes, T. A., & Amir, E. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.220 · Cited by 432
Pan-cancer deconvolution of tumour composition using DNA methylation
Chakravarthy, A., Furness, A., Joshi, K., Ghorani, E., Ford, K., Ward, M. J., King, E. V., Lechner, M., Marafioti, T., Quezada, S. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05570-1 · Cited by 327
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma
Nguyen, N., Bellile, E., Thomas, D., McHugh, J., Rozek, L., Virani, S., Peterson, L., Carey, T. E., Walline, H., Moyer, J., et al. (2016) · Head & Neck · doi:10.1002/hed.24406 · Cited by 353
Metadata
- Authors
- Balermpas, P., Michel, Y., Wagenblast, J., Seitz, O., Weiss, C., Rödel, F., Rödel, C., & Fokas, E.
- Venue
- British Journal of Cancer
- Published
- 2013-10-15
- Volume
- 110
- Issue
- 2
- Pages
- 501-509
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1970151745
- Cited by
- 309
- References
- 40
- FWCI
- 16.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.